Businessweek

Cymer Inc., Special/Extraordinary Shareholders Meeting, Feb 05, 2013.

Cymer Inc. announced that Dr. Klaus Schuegraf has joined the company as group vice president of EUV product development. In this role, Dr. Schuegraf will oversee Cymer's EUV engineering and development programs. Prior to joining Cymer, Dr. Schuegraf was corporate vice president and chief technology officer for the Silicon Systems Group of Applied Materials responsible for overseeing the semiconductor products technology roadmap.

The Shareholders Foundation Inc. announces that an investor filed a lawsuit for current stockholders in shares of Cymer Inc. in effort to stop the proposed takeover of Cymer Inc. at a value of approximately $81.64 per share. Investors who purchased shares of Cymer Inc. prior to October 17, 2012 and currently hold any of those CYMI shares, have certain options and should contact the Shareholders Foundation Inc. On October 17, 2012, Cymer Inc. and ASML Holding NV announced that they have entered into an agreement under which ASML Holding NV will acquire all outstanding shares of Cymer in a cash-and-stock transaction. Based on a closing price of ASML Holding NV shares on October 16, 2012, of $53.59, Cymer stockholders would receive a value of approximately $81.64 per CYMI share.

Cymer Inc. announced unaudited consolidated financial results for the third quarter and nine months ended September 30, 2012. For the quarter, the company reported revenue of $131.478 million against $128.698 million a year ago. Operating income was $9.046 million against $13.406 million a year ago. Income before income taxes was $8.773 million against $13.394 million a year ago. Net income was $9.826 million or $0.31 per diluted share against $11.250 million or $0.36 per diluted share a year ago. For the nine months, the company reported revenue of $431.288 million against $441.331 million a year ago. Operating income was $36.940 million against $85.975 million a year ago. Income before income taxes was $36.571 million against $86.796 million a year ago. Net income was $40.960 million or $1.29 per diluted share against $67.770 million or $2.19 per diluted share a year ago. Net cash provided by operating activities was $18.300 million against $60.376 million a year ago. Acquisition of property, plant and equipment was $41.580 million against $14.837 million a year ago.

Cymer Inc. announced that they will report Q3, 2012 results at 8:25 PM, GMT Standard Time on Oct 26, 2012